Anticancer effects of rosemary (Rosmarinus officinalis L.) extract and rosemary extract polyphenols

Nutrients

Volumn 8, Issue 11, 2016, Pages

  Moore, Jessy ^a   Yousef, Michael ^a   Tsiani, Evangelia ^a  

^a BROCK UNIVERSITY   (Canada)

Author keywords

Cancer; Carnosic acid; Cell signaling; Proliferation; Rosemary extract; Rosmarinic acid; Survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARNOSIC ACID; CASPASE; CYTOCHROME C; DIETHYLNITROSAMINE; DIMETHYLBENZ[A]ANTHRACENE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEME OXYGENASE 1; HYDROGEN PEROXIDE; LIPID PEROXIDASE; MICRORNA; MICRORNA 15B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; POLYPHENOL; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PUMA PROTEIN; REACTIVE OXYGEN METABOLITE; ROSMARINIC ACID; ROSMARINUS OFFICINALIS EXTRACT; THYMIDINE KINASE 1; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR NRF2; UNINDEXED DRUG; VITAMIN D; ANTINEOPLASTIC AGENT; CINNAMIC ACID DERIVATIVE; DEPSIDE; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER INCIDENCE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CYTOTOXICITY; GI50; HUMAN; IC50; NONHUMAN; REVIEW; ROSEMARY; SIGNAL TRANSDUCTION; TUMOR VOLUME; UNFOLDED PROTEIN RESPONSE; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; NEOPLASMS; PATHOLOGY; PHYTOTHERAPY; ROSMARINUS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CINNAMATES; DEPSIDES; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; POLYPHENOLS; ROSMARINUS; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84996483426     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8110731     Document Type: Review

References (121)

1. Hanahan,D.; Weinberg,R.A. Hallmarks of Cancer: The Next Generation. Cell 2011,144,646-674. [CrossRef] [PubMed]
2. Bhowmick,N.A.; Neilson,E.G.; Moses,H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004,432,332-337. [CrossRef] [PubMed]
3. Cheng,N.; Chytil,A.; Shyr,Y.; Joly,A.; Moses,H.L. Transforming Growth Factor-β Signaling-Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion. Mol. Cancer Res. 2008,6,1521-1533. [CrossRef] [PubMed]
4. Da Rocha,A.B.; Lopes,R.M.; Schwartsmann,G. Natural products in anticancer therapy. Curr. Opin. Pharmacol. 2001,1,364-369. [CrossRef]
5. Storozhuk,Y.; Hopmans,S.N.; Sanli,T.; Barron,C.; Tsiani,E.; Cutz,J.-C.; Pond,G.; Wright,J.; Singh,G.; Tsakiridis,T. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Br. J. Cancer 2013,108,2021-2032. [CrossRef] [PubMed]
6. Bai,Y.; Mao,Q.-Q.; Qin,J.; Zheng,X.-Y.; Wang,Y.-B.; Yang,K.; Shen,H.-F.; Xie,L.-P. Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 2010,101,488-493. [CrossRef] [PubMed]
7. Rashid,A.; Liu,C.; Sanli,T.; Tsiani,E.; Singh,G.; Bristow,R.G.; Dayes,I.; Lukka,H.; Wright,J.; Tsakiridis,T. Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK,Akt and mTOR pathways. Radiat. Oncol. 2011,6,144. [CrossRef] [PubMed]
8. Varoni,E.M.; Lo Faro,A.F.; Sharifi-Rad,J.; Iriti,M. Anticancer Molecular Mechanisms of Resveratrol. Front. Nutr. 2016,3. [CrossRef] [PubMed]
9. Aggarwal,B.B.; Bhardwaj,A.; Aggarwal,R.S.; Seeram,N.P.; Shishodia,S.; Takada,Y. Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies. Anticancer Res. 2004,24,2783-2840. [PubMed]
10. Barron,C.C.; Moore,J.; Tsakiridis,T.; Pickering,G.; Tsiani,E. Inhibition of human lung cancer cell proliferation and survival by wine. Cancer Cell Int. 2014,14,6. [CrossRef] [PubMed]
11. Cuvelier,M.E.; Berset,C.; Richard,H. Antioxidant Constituents in Sage (Salvia officinalis). J. Agric. Food Chem. 1994,42,665-669. [CrossRef]
12. González-Vallinas,M.; Reglero,G.; Ramírez de Molina,A. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy. Nutr. Cancer 2015,67,1221-1229. [CrossRef] [PubMed]
13. Petiwala,S.M.; Puthenveetil,A.G.; Johnson,J.J. Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer. Front. Pharmacol. 2013,4,e1-e4. [CrossRef] [PubMed]
14. Petiwala,S.M.; Johnson,J.J. Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity. Cancer Lett. 2015,367,93-102. [CrossRef] [PubMed]
15. Slamenova,D.; Kuboskova,K.; Horvathova,E.; Robichova,S. Rosemary-stimulated reduction of DNA strand breaks and FPG-sensitive sites in mammalian cells treated with H2O2 or visible light-excited Methylene Blue. Cancer Lett. 2002,177,145-153. [CrossRef]
16. Yi,W.; Wetzstein,H.Y. Anti-tumorigenic activity of five culinary and medicinal herbs grown under greenhouse conditions and their combination effects. J. Sci. Food Agric. 2011,91,1849-1854. [CrossRef] [PubMed]
17. Ibáñez,C.; Simó,C.; García-Cañas,V.; Gómez-Martínez,Á.; Ferragut,J.A.; Cifuentes,A. CE/LC-MS multiplatform for broad metabolomic analysis of dietary polyphenols effect on colon cancer cells proliferation. Electrophoresis 2012,33,2328-2336. [CrossRef] [PubMed]
18. Ðilas,S.; Knez,Ž.; Četojević-Simin,D.; Tumbas,V.; Škerget,M.; Čanadanović-Brunet,J.; Ćetković,G. In vitro antioxidant and antiproliferative activity of three rosemary (Rosmarinus officinalis L.) extract formulations. Int. J. Food Sci. Technol. 2012,47,2052-2062. [CrossRef]
19. Valdés,A.; Garcia-Canas,V.; Rocamora-Reverte,L.; Gomez-Martinez,A.; Ferragut,J.A.; Cifuentes,A. Effect of rosemary polyphenols on human colon cancer cells: Transcriptomic profiling and functional enrichment analysis. Genes Nutr. 2013,8,43-60. [CrossRef] [PubMed]
20. González-Vallinas,M.; Molina,S.; Vicente,G.; de la Cueva,A.; Vargas,T.; Santoyo,S.; García-Risco,M.R.; Fornari,T.; Reglero,G.; Ramírez de Molina,A. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol. Res. 2013,72,61-68. [CrossRef] [PubMed]
21. González-Vallinas,M.; Molina,S.; Vicente,G.; Zarza,V.; Martín-Hernández,R.; García-Risco,M.R.; Fornari,T.; Reglero,G.; de Molina,A.R. Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer. PLoS ONE 2014,9,e98556. [CrossRef] [PubMed]
22. Borrás-Linares,I.; Pérez-Sánchez,A.; Lozano-Sánchez,J.; Barrajón-Catalán,E.; Arráez-Román,D.; Cifuentes,A.; Micol,V.; Carretero,A.S. A bioguided identification of the active compounds that contribute to the antiproliferative/cytotoxic effects of rosemary extract on colon cancer cells. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2015,80,215-222. [CrossRef] [PubMed]
23. Yan,M.; Li,G.; Petiwala,S.M.; Householter,E.; Johnson,J.J. Standardized rosemary (Rosmarinus officinalis) extract induces Nrf2/sestrin-2 pathway in colon cancer cells. J. Funct. Foods 2015,13,137-147. [CrossRef]
24. Valdés,A.; Sullini,G.; Ibáñez,E.; Cifuentes,A.; García-Cañas,V. Rosemary polyphenols induce unfolded protein response and changes in cholesterol metabolism in colon cancer cells. J. Funct. Foods 2015,15,429-439. [CrossRef]
25. Valdés,A.; García-Cañas,V.; Koçak,E.; Simó,C.; Cifuentes,A. Foodomics study on the effects of extracellular production of hydrogen peroxide by rosemary polyphenols on the anti-proliferative activity of rosemary polyphenols against HT-29 cells. Electrophoresis 2016,37,1795-1804. [CrossRef] [PubMed]
26. Valdés,A.; Artemenko,K.A.; Bergquist,J.; García-Cañas,V.; Cifuentes,A. Comprehensive Proteomic Study of the Antiproliferative Activity of a Polyphenol-Enriched Rosemary Extract on Colon Cancer Cells Using Nanoliquid Chromatography-Orbitrap MS/MS. J. Proteome Res. 2016,15,1971-1985. [CrossRef] [PubMed]
27. Kontogianni,V.G.; Tomic,G.; Nikolic,I.; Nerantzaki,A.A.; Sayyad,N.; Stosic-Grujicic,S.; Stojanovic,I.; Gerothanassis,I.P.; Tzakos,A.G. Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem. 2013,136,120-129. [CrossRef] [PubMed]
28. Alexandrov,K.; Rojas,M.; Rolando,C. DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract,which lowers free radicals. Cancer Res. 2006,66,11938-11945. [CrossRef] [PubMed]
29. Cheung,S.; Tai,J. Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol. Rep. 2007,17,1525-1531. [CrossRef] [PubMed]
30. Yesil-Celiktas,O.; Sevimli,C.; Bedir,E.; Vardar-Sukan,F. Inhibitory Effects of Rosemary Extracts,Carnosic Acid and Rosmarinic Acid on the Growth of Various Human Cancer Cell Lines. Plant Foods Hum. Nutr. 2010,65,158-163. [CrossRef] [PubMed]
31. Mothana,R.A.A.; Kriegisch,S.; Harms,M.; Wende,K.; Lindequist,U. Assessment of selected Yemeni medicinal plants for their in vitro antimicrobial,anticancer,and antioxidant activities. Pharm. Biol. 2011,49,200-210. [CrossRef] [PubMed]
32. González-Vallinas,M.; Molina,S.; Vicente,G.; Sánchez-Martínez,R.; Vargas,T.; García-Risco,M.R.; Fornari,T.; Reglero,G.; Ramírez de Molina,A. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells. Electrophoresis 2014,35,1719-1727. [CrossRef] [PubMed]
33. Petiwala,S.M.; Berhe,S.; Li,G.; Puthenveetil,A.G.; Rahman,O.; Nonn,L.; Johnson,J.J. Rosemary (Rosmarinus officinalis) Extract Modulates CHOP/GADD153 to Promote Androgen Receptor Degradation and Decreases Xenograft Tumor Growth. PLoS ONE 2014,9,e89772. [CrossRef] [PubMed]
34. Tai,J.; Cheung,S.;Wu,M.; Hasman,D. Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Phytomedicine 2012,19,436-443. [CrossRef] [PubMed]
35. Berrington,D.; Lall,N. Anticancer Activity of Certain Herbs and Spices on the Cervical Epithelial Carcinoma (HeLa) Cell Line. Evid. Based Complement. Alternat. Med. 2012,2012,e564927. [CrossRef] [PubMed]
36. Wang,W.; Li,N.; Luo,M.; Zu,Y.; Efferth,T. Antibacterial Activity and Anticancer Activity of Rosmarinus officinalis L. Essential Oil Compared to That of Its Main Components. Molecules 2012,17,2704-2713. [CrossRef] [PubMed]
37. Peng,C.-H.; Su,J.-D.; Chyau,C.-C.; Sung,T.-Y.; Ho,S.-S.; Peng,C.-C.; Peng,R.Y. Supercritical Fluid Extracts of Rosemary Leaves Exhibit Potent Anti-Inflammation and Anti-Tumor Effects. Biosci. Biotechnol. Biochem. 2007,71,2223-2232. [CrossRef] [PubMed]
38. Vicente,G.; Molina,S.; González-Vallinas,M.; García-Risco,M.R.; Fornari,T.; Reglero,G.; de Molina,A.R. Supercritical rosemary extracts,their antioxidant activity and effect on hepatic tumor progression. J. Supercrit. Fluids 2013,79,101-108. [CrossRef]
39. Moore,J.; Megaly,M.; MacNeil,A.J.; Klentrou,P.; Tsiani,E. Rosemary extract reduces Akt/mTOR/p70S6K activation and inhibits proliferation and survival of A549 human lung cancer cells. Biomed. Pharmacother. 2016,83,725-732. [CrossRef] [PubMed]
40. Shabtay,A.; Sharabani,H.; Barvish,Z.; Kafka,M.; Amichay,D.; Levy,J.; Sharoni,Y.; Uskokovic,M.R.; Studzinski,G.P.; Danilenko,M. Synergistic Antileukemic Activity of Carnosic Acid-Rich Rosemary Extract and the 19-nor Gemini Vitamin D Analogue in a Mouse Model of Systemic Acute Myeloid Leukemia. Oncology 2008,75,203-214. [CrossRef] [PubMed]
41. Sharabani,H.; Izumchenko,E.; Wang,Q.; Kreinin,R.; Steiner,M.; Barvish,Z.; Kafka,M.; Sharoni,Y.; Levy,J.; Uskokovic,M.; et al. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int. J. Cancer 2006,118,3012-3021. [CrossRef] [PubMed]
42. Okumura,N.; Yoshida,H.; Nishimura,Y.; Kitagishi,Y.; Matsuda,S. Terpinolene,a component of herbal sage,downregulates AKT1 expression in K562 cells. Oncol. Lett. 2012,3,321-324. [PubMed]
43. Ahmad,H.H.; Hamza,A.H.; Hassan,A.Z.; Sayed,A.H. Promising therapeutic role of Rosmarinus officinalis successive methanolic fraction against colorectal cancer. Int. J. Pharm. Pharm. Sci. 2013,5,164-170.
44. Kitano,M.; Wanibuchi,H.; Kikuzaki,H.; Nakatani,N.; Imaoka,S.; Funae,Y.; Hayashi,S.; Fukushima,S. Chemopreventive effects of coumaperine from pepper on the initiation stage of chemical hepatocarcinogenesis in the rat. Jpn. J. Cancer Res. Gann 2000,91,674-680. [CrossRef] [PubMed]
45. Soyal,D.; Jindal,A.; Singh,I.; Goyal,P.K. Modulation of radiation-induced biochemical alterations in mice by rosemary (Rosemarinus officinalis) extract. Phytomed. Int. J. Phytother. Phytopharm. 2007,14,701-705. [CrossRef] [PubMed]
46. Sancheti,G.; Goyal,P. Modulatory influence of Rosemarinus officinalis on DMBA-induced mouse skin tumorigenesis. Asian Pac. J. Cancer Prev. 2006,7,331-335. [PubMed]
47. Sancheti,G.; Goyal,P.K. Effect of Rosmarinus officinalis in modulating 7,12-dimethylbenz(a)anthracene induced skin tumorigenesis in mice. Phytother. Res. 2006,20,981-986. [CrossRef] [PubMed]
48. Visanji,J.M.; Thompson,D.G.; Padfield,P.J. Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett. 2006,237,130-136. [CrossRef] [PubMed]
49. Barni,M.V.; Carlini,M.J.; Cafferata,E.G.; Puricelli,L.; Moreno,S. Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol. Rep. 2012,27,1041-1048. [PubMed]
50. De la Roche,M.; Rutherford,T.J.; Gupta,D.; Veprintsev,D.B.; Saxty,B.; Freund,S.M.; Bienz,M. An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid. Nat. Commun. 2012,3,680. [CrossRef] [PubMed]
51. Valdés,A.; García-Cañas,V.; Simó,C.; Ibáñez,C.; Micol,V.; Ferragut,J.A.; Cifuentes,A. Comprehensive Foodomics Study on the Mechanisms Operating at Various Molecular Levels in Cancer Cells in Response to Individual Rosemary Polyphenols. Anal. Chem. 2014,86,9807-9815. [CrossRef] [PubMed]
52. Kim,Y.-J.; Kim,J.-S.; Seo,Y.-R.; Park,J.-H.Y.; Choi,M.-S.; Sung,M.-K. Carnosic acid suppresses colon tumor formation in association with anti-adipogenic activity. Mol. Nutr. Food Res. 2014,58,2274-2285. [CrossRef] [PubMed]
53. Kim,D.-H.; Park,K.-W.; Chae,I.G.; Kundu,J.; Kim,E.-H.; Kundu,J.K.; Chun,K.-S. Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells. Mol. Carcinog. 2016,55,1096-1110. [CrossRef] [PubMed]
54. Einbond,L.S.; Wu,H.; Kashiwazaki,R.; He,K.; Roller,M.; Su,T.; Wang,X.; Goldsberry,S. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Fitoterapia 2012,83,1160-1168. [CrossRef] [PubMed]
55. Min,K.-J.; Jung,K.-J.; Kwon,T.K. Carnosic Acid Induces Apoptosis Through Reactive Oxygen Species-mediated Endoplasmic Reticulum Stress Induction in Human Renal Carcinoma Caki Cells. J. Cancer Prev. 2014,19,170-178. [CrossRef] [PubMed]
56. Jung,K.-J.; Min,K.; Bae,J.H.; Kwon,T.K. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5,Bim,and PUMA expression in human carcinoma caki cells. Oncotarget 2015,6,1556-1568. [CrossRef] [PubMed]
57. Linnewiel-Hermoni,K.; Khanin,M.; Danilenko,M.; Zango,G.; Amosi,Y.; Levy,J.; Sharoni,Y. The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity. Arch. Biochem. Biophys. 2015,572,28-35. [CrossRef] [PubMed]
58. Kar,S.; Palit,S.; Ball,W.B.; Das,P.K. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis Int. J. Program. Cell Death 2012,17,735-747. [CrossRef] [PubMed]
59. Gao,Q.; Liu,H.; Yao,Y.; Geng,L.; Zhang,X.; Jiang,L.; Shi,B.; Yang,F. Carnosic acid induces autophagic cell death through inhibition of the Akt/mTOR pathway in human hepatoma cells. J. Appl. Toxicol. 2014,485-492. [CrossRef] [PubMed]
60. Lin,C.-Y.; Wu,C.-R.; Chang,S.-W.; Wang,Y.-J.; Wu,J.-J.; Tsai,C.-W. Induction of the pi class of glutathione S-transferase by carnosic acid in rat Clone 9 cells via the p38/Nrf2 pathway. Food Funct. 2015,6,1936-1943. [CrossRef] [PubMed]
61. Tsai,C.-W.; Lin,C.-Y.;Wang,Y.-J. Carnosic acid induces the NAD(P)H: Quinone oxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 pathway. J. Nutr. 2011,141,2119-2125. [CrossRef] [PubMed]
62. López-Jiménez,A.; García-Caballero,M.; Medina,M.Á.; Quesada,A.R. Anti-angiogenic properties of carnosol and carnosic acid,two major dietary compounds from rosemary. Eur. J. Nutr. 2013,52,85-95. [CrossRef] [PubMed]
63. Park,S.Y.; Song,H.; Sung,M.-K.; Kang,Y.-H.; Lee,K.W.; Park,J.H.Y. Carnosic Acid Inhibits the Epithelial-Mesenchymal Transition in B16F10 Melanoma Cells: A Possible Mechanism for the Inhibition of Cell Migration. Int. J. Mol. Sci. 2014,15,12698-12713. [CrossRef] [PubMed]
64. Kosaka,K.; Yokoi,T. Carnosic acid,a component of rosemary (Rosmarinus officinalis L.),promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol. Pharm. Bull. 2003,26,1620-1622. [CrossRef] [PubMed]
65. Mimura,J.; Kosaka,K.; Maruyama,A.; Satoh,T.; Harada,N.; Yoshida,H.; Satoh,K.; Yamamoto,M.; Itoh,K. Nrf2 regulates NGF mRNA induction by carnosic acid in T98G glioblastoma cells and normal human astrocytes. J. Biochem. 2011,150,209-217. [CrossRef] [PubMed]
66. Tsai,C.-W.; Lin,C.-Y.; Lin,H.-H.; Chen,J.-H. Carnosic acid,a rosemary phenolic compound,induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells. Neurochem. Res. 2011,36,2442-2451. [CrossRef] [PubMed]
67. De Oliveira,M.R.; Ferreira,G.C.; Schuck,P.F.; dal Bosco,S.M. Role for the PI3K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Chem. Biol. Interact. 2015,242,396-406. [CrossRef] [PubMed]
68. Meng,P.; Yoshida,H.; Tanji,K.; Matsumiya,T.; Xing,F.; Hayakari,R.; Wang,L.; Tsuruga,K.; Tanaka,H.; Mimura,J.; et al. Carnosic acid attenuates apoptosis induced by amyloid-β 1-42 or 1-43 in SH-SY5Y human neuroblastoma cells. Neurosci. Res. 2015,94,1-9. [CrossRef] [PubMed]
69. Yoshida,H.; Meng,P.; Matsumiya,T.; Tanji,K.; Hayakari,R.; Xing,F.; Wang,L.; Tsuruga,K.; Tanaka,H.; Mimura,J.; et al. Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells. Neurosci. Res. 2014,79,83-93. [CrossRef] [PubMed]
70. Cortese,K.; Daga,A.; Monticone,M.; Tavella,S.; Stefanelli,A.; Aiello,C.; Bisio,A.; Bellese,G.; Castagnola,P. Carnosic acid induces proteasomal degradation of Cyclin B1,RB and SOX2 along with cell growth arrest and apoptosis in GBM cells. Phytomed. Int. J. Phytother. Phytopharm. 2016,23,679-685. [CrossRef] [PubMed]
71. Danilenko,M.; Wang,X.; Studzinski,G.P. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J. Natl. Cancer Inst. 2001,93,1224-1233. [CrossRef] [PubMed]
72. Steiner,M. Carnosic Acid Inhibits Proliferation and Augments Differentiation of Human Leukemic Cells Induced by 1,25-Dihydroxyvitamin Dsub3 and Retinoic Acid. Nutr. Cancer 2001,41,135-144. [CrossRef] [PubMed]
73. Danilenko,M.; Wang,Q.; Wang,X.; Levy,J.; Sharoni,Y.; Studzinski,G.P. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res. 2003,63,1325-1332. [PubMed]
74. Wang,Q.; Harrison,J.S.; Uskokovic,M.; Kutner,A.; Studzinski,G.P. Translational study of vitamin D differentiation therapy of myeloid leukemia: Effects of the combination with a p38 MAPK inhibitor and an antioxidant. Leukemia 2005,19,1812-1817. [CrossRef] [PubMed]
75. Chen-Deutsch,X.; Garay,E.; Zhang,J.; Harrison,J.S.; Studzinski,G.P. c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D. Leuk. Res. 2009,33,1372-1378. [CrossRef] [PubMed]
76. Chen-Deutsch,X.; Studzinski,G.P. Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance. Cell. Cycle Georget. Tex 2012,11,1364-1373. [CrossRef] [PubMed]
77. Bobilev,I.; Novik,V.; Levi,I.; Shpilberg,O.; Levy,J.; Sharoni,Y.; Studzinski,G.P.; Danilenko,M. The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells. Cancer Biol. Ther. 2011,11,317-329. [CrossRef] [PubMed]
78. Nachliely,M.; Sharony,E.; Kutner,A.; Danilenko,M. Novel analogs of 1,25-dihydroxyvitamin D2 combined with a plant polyphenol as highly efficient inducers of differentiation in human acute myeloid leukemia cells. J. Steroid Biochem. Mol. Biol. 2016,164,59-65. [CrossRef] [PubMed]
79. Nishimoto,S.; Suzuki,T.; Koike,S.; Yuan,B.; Takagi,N.; Ogasawara,Y. Nrf2 activation ameliorates cytotoxic effects of arsenic trioxide in acute promyelocytic leukemia cells through increased glutathione levels and arsenic efflux from cells. Toxicol. Appl. Pharmacol. 2016,305,161-168. [CrossRef] [PubMed]
80. Yu,X.-N.; Chen,X.-L.; Li,H.; Li,X.-X.; Li,H.-Q.; Jin,W.-R. Reversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by carnosic acid. Chin. J. Physiol. 2008,51,348-356. [PubMed]
81. Duggal,J.; Harrison,J.S.; Studzinski,G.P.;Wang,X. Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia cells. MicroRNA Shāriqah. United Arab Emir. 2012,1,26-33. [CrossRef]
82. Wang,R.; Cong,W.; Guo,G.; Li,X.; Chen,X.; Yu,X.; Li,H. Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway. Chin. J. Integr. Med. 2012,18,934-941. [CrossRef] [PubMed]
83. Manoharan,S.; Vasanthaselvan,M.; Silvan,S.; Baskaran,N.; Kumar Singh,A.; Vinoth Kumar,V. Carnosic acid: A potent chemopreventive agent against oral carcinogenesis. Chem. Biol. Interact. 2010,188,616-622. [CrossRef] [PubMed]
84. Rajasekaran,D.; Manoharan,S.; Silvan,S.; Vasudevan,K.; Baskaran,N.; Palanimuthu,D. Proapoptotic,anti-cell proliferative,anti-inflammatory and anti-angiogenic potential of carnosic acid during 7,12 dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Afr. J. Tradit. Complement. Altern. Med. AJTCAM Afr. Netw. Ethnomed. 2012,10,102-112.
85. Gómez-García,F.; López-Jornet,M.; Álvarez-Sánchez,N.; Castillo-Sánchez,J.; Benavente-García,O.; Vicente Ortega,V. Effect of the phenolic compounds apigenin and carnosic acid on oral carcinogenesis in hamster induced by DMBA. Oral Dis. 2013,19,279-286. [CrossRef] [PubMed]
86. Petiwala,S.M.; Li,G.; Bosland,M.C.; Lantvit,D.D.; Petukhov,P.A.; Johnson,J.J. Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo. Carcinogenesis 2016,37,827-838. [CrossRef] [PubMed]
87. Wang,L.-Q.; Wang,R.; Li,X.-X.; Yu,X.-N.; Chen,X.-L.; Li,H. The anti-leukemic effect of carnosic acid combined with Adriamycin in a K562/A02/SCID leukemia mouse model. Int. J. Clin. Exp. Med. 2015,8,11708-11717. [PubMed]
88. Scheckel,K.A.; Degner,S.C.; Romagnolo,D.F. Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines. J. Nutr. 2008,138,2098-2105. [CrossRef] [PubMed]
89. Xavier,C.P.R.; Lima,C.F.; Fernandes-Ferreira,M.; Pereira-Wilson,C. Salvia fruticosa,Salvia officinalis,and rosmarinic acid induce apoptosis and inhibit proliferation of human colorectal cell lines: The role in MAPK/ERK pathway. Nutr. Cancer 2009,61,564-571. [CrossRef] [PubMed]
90. Xu,Y.; Xu,G.; Liu,L.; Xu,D.; Liu,J. Anti-invasion effect of rosmarinic acid via the extracellular signal-regulated kinase and oxidation-reduction pathway in Ls174-T cells. J. Cell. Biochem. 2010,111,370-379. [CrossRef] [PubMed]
91. Ramos,A.A.; Pedro,D.; Collins,A.R.; Pereira-Wilson,C. Protection by Salvia extracts against oxidative and alkylation damage to DNA in human HCT15 and CO115 cells. J. Toxicol. Environ. Health A 2012,75,765-775. [CrossRef] [PubMed]
92. Moon,D.-O.; Kim,M.-O.; Lee,J.-D.; Choi,Y.H.; Kim,G.-Y. Rosmarinic acid sensitizes cell death through suppression of TNF-α-induced NF-κB activation and ROS generation in human leukemia U937 cells. Cancer Lett. 2010,288,183-191. [CrossRef] [PubMed]
93. Paluszczak,J.; Krajka-Kúzniak,V.; Baer-Dubowska,W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 2010,192,119-125. [CrossRef] [PubMed]
94. Berdowska,I.; Zielínski,B.; Fecka,I.; Kulbacka,J.; Saczko,J.; Gamian,A. Cytotoxic impact of phenolics from Lamiaceae species on human breast cancer cells. Food Chem. 2013,141,1313-1321. [CrossRef] [PubMed]
95. Li,F.-R.; Fu,Y.-Y.; Jiang,D.-H.; Wu,Z.; Zhou,Y.-J.; Guo,L.; Dong,Z.-M.; Wang,Z.-Z. Reversal effect of rosmarinic acid on multidrug resistance in SGC7901/Adr cell. J. Asian Nat. Prod. Res. 2013,15,276-285. [CrossRef] [PubMed]
96. Han,S.; Yang,S.; Cai,Z.; Pan,D.; Li,Z.; Huang,Z.; Zhang,P.; Zhu,H.; Lei,L.; Wang,W. Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells. Drug Des. Dev. Ther. 2015,9,2695-2703.
97. Lee,J.; Kim,Y.S.; Park,D. Rosmarinic acid induces melanogenesis through protein kinase A activation signaling. Biochem. Pharmacol. 2007,74,960-968. [CrossRef] [PubMed]
98. Renzulli,C.; Galvano,F.; Pierdomenico,L.; Speroni,E.; Guerra,M.C. Effects of rosmarinic acid against aflatoxin B1 and ochratoxin-A-induced cell damage in a human hepatoma cell line (HepG2). J. Appl. Toxicol. 2004,24,289-296. [CrossRef] [PubMed]
99. Lin,C.-S.; Kuo,C.-L.;Wang,J.-P.; Cheng,J.-S.; Huang,Z.-W.; Chen,C.-F. Growth inhibitory and apoptosis inducing effect of Perilla frutescens extract on human hepatoma HepG2 cells. J. Ethnopharmacol. 2007,112,557-567. [CrossRef] [PubMed]
100. Wu,J.; Zhu,Y.; Li,F.; Zhang,G.; Shi,J.; Ou,R.; Tong,Y.; Liu,Y.; Liu,L.; Lu,L.; et al. Spica prunellae and its marker compound rosmarinic acid induced the expression of efflux transporters through activation of Nrf2-mediated signaling pathway in HepG2 cells. J. Ethnopharmacol. 2016,193,1-11. [CrossRef] [PubMed]
101. Tao,L.; Wang,S.; Zhao,Y.; Sheng,X.; Wang,A.; Zheng,S.; Lu,Y. Phenolcarboxylic acids from medicinal herbs exert anticancer effects through disruption of COX-2 activity. Phytomed. Int. J. Phytother. Phytopharm. 2014,21,1473-1482. [CrossRef] [PubMed]
102. Aquilano,K.; Filomeni,G.; Di Renzo,L.; Vito,M.D.; Stefano,C.D.; Salimei,P.S.; Ciriolo,M.R.; Marfè,G. Reactive oxygen and nitrogen species are involved in sorbitol-induced apoptosis of human erithroleukaemia cells K562. Free Radic. Res. 2007,41,452-460. [CrossRef] [PubMed]
103. Heo,S.-K.; Noh,E.-K.; Yoon,D.-J.; Jo,J.-C.; Koh,S.; Baek,J.H.; Park,J.-H.; Min,Y.J.; Kim,H. Rosmarinic acid potentiates ATRA-induced macrophage differentiation in acute promyelocytic leukemia NB4 cells. Eur. J. Pharmacol. 2015,747,36-44. [CrossRef] [PubMed]
104. Saiko,P.; Steinmann,M.-T.; Schuster,H.; Graser,G.; Bressler,S.; Giessrigl,B.; Lackner,A.; Grusch,M.; Krupitza,G.; Bago-Horvath,Z.; et al. Epigallocatechin gallate,ellagic acid,and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine. Phytomedicine 2015,22,213-222. [CrossRef] [PubMed]
105. Wu,C.-F.; Hong,C.; Klauck,S.M.; Lin,Y.-L.; Efferth,T. Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells. J. Ethnopharmacol. 2015,176,55-68. [CrossRef] [PubMed]
106. Lozano-Baena,M.-D.; Tasset,I.; Muñoz-Serrano,A.; Alonso-Moraga,Á.; de Haro-Bailón,A. Cancer Prevention and Health Benefices of Traditionally Consumed Borago officinalis Plants. Nutrients 2016,8,48. [CrossRef] [PubMed]
107. Osakabe,N.; Yasuda,A.; Natsume,M.; Yoshikawa,T. Rosmarinic acid inhibits epidermal inflammatory responses: Anticarcinogenic effect of Perilla frutescens extract in the murine two-stage skin model. Carcinogenesis 2004,25,549-557. [CrossRef] [PubMed]
108. Anusuya,C.; Manoharan,S. Antitumor initiating potential of rosmarinic acid in 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. Off. Organ Int. Soc. Environ. Toxicol. Cancer 2011,30,199-211. [CrossRef]
109. Karmokar,A.; Marczylo,T.H.; Cai,H.; Steward,W.P.; Gescher,A.J.; Brown,K. Dietary intake of rosmarinic acid by Apc(Min) mice,a model of colorectal carcinogenesis: Levels of parent agent in the target tissue and effect on adenoma development. Mol. Nutr. Food Res. 2012,56,775-783. [CrossRef] [PubMed]
110. Karthikkumar,V.; Sivagami,G.; Vinothkumar,R.; Rajkumar,D.; Nalini,N. Modulatory efficacy of rosmarinic acid on premalignant lesions and antioxidant status in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Environ. Toxicol. Pharmacol. 2012,34,949-958. [CrossRef] [PubMed]
111. Sharmila,R.; Manoharan,S. Anti-tumor activity of rosmarinic acid in 7,12-dimethylbenz(a)anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. Indian J. Exp. Biol. 2012,50,187-194. [PubMed]
112. Venkatachalam,K.; Gunasekaran,S.; Jesudoss,V.A.S.; Namasivayam,N. The effect of rosmarinic acid on 1,2-dimethylhydrazine induced colon carcinogenesis. Exp. Toxicol. Pathol. 2013,65,409-418. [CrossRef] [PubMed]
113. Baldasquin-Caceres,B.; Gomez-Garcia,F.J.; López-Jornet,P.; Castillo-Sanchez,J.; Vicente-Ortega,V. Chemopreventive potential of phenolic compounds in oral carcinogenesis. Arch. Oral Biol. 2014,59,1101-1107. [CrossRef] [PubMed]
114. Furtado,R.A.; Oliveira,B.R.; Silva,L.R.; Cleto,S.S.; Munari,C.C.; Cunha,W.R.; Tavares,D.C. Chemopreventive effects of rosmarinic acid on rat colon carcinogenesis. Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ. ECP 2015,24,106-112. [CrossRef] [PubMed]
115. Romo Vaquero,M.; García Villalba,R.; Larrosa,M.; Yáñez-Gascón,M.J.; Fromentin,E.; Flanagan,J.; Roller,M.; Tomás-Barberán,F.A.; Espín,J.C.; García-Conesa,M.-T. Bioavailability of the major bioactive diterpenoids in a rosemary extract: Metabolic profile in the intestine,liver,plasma,and brain of Zucker rats. Mol. Nutr. Food Res. 2013,57,1834-1846. [CrossRef] [PubMed]
116. Doolaege,E.H.A.; Raes,K.; Vos,F.D.; Verhé,R.; Smet,S.D. Absorption,Distribution and Elimination of Carnosic Acid,A Natural Antioxidant from Rosmarinus officinalis,in Rats. Plant Foods Hum. Nutr. 2011,66,196-202. [CrossRef] [PubMed]
117. Karthikkumar,V.; Sivagami,G.; Viswanathan,P.; Nalini,N. Rosmarinic acid inhibits DMH-induced cell proliferation in experimental rats. J. Basic Clin. Physiol. Pharmacol. 2015,26,185-200. [CrossRef] [PubMed]
118. Romo-Vaquero,M.; Larrosa,M.; Yáñez-Gascón,M.J.; Issaly,N.; Flanagan,J.; Roller,M.; Tomás-Barberán,F.A.; Espín,J.C.; García-Conesa,M.-T. A rosemary extract enriched in carnosic acid improves circulating adipocytokines and modulates key metabolic sensors in lean Zucker rats: Critical and contrasting differences in the obese genotype. Mol. Nutr. Food Res. 2014,58,942-953. [CrossRef] [PubMed]
119. European Food Safety Authority (EFSA). Use of rosemary extracts as a food additive-Scientific Opinion of the Panel on Food Additives,Flavourings,Processing Aids and Materials in Contact with Food. EFSA J. 2008,6,1-29.
120. Pérez-Sánchez,A.; Barrajón-Catalán,E.; Caturla,N.; Castillo,J.; Benavente-García,O.; Alcaraz,M.; Micol,V. Protective effects of citrus and rosemary extracts on UV-induced damage in skin cell model and human volunteers. J. Photochem. Photobiol. B 2014,136,12-18. [CrossRef] [PubMed]
121. Romo-Vaquero,M.; Selma,M.-V.; Larrosa,M.; Obiol,M.; García-Villalba,R.; González-Barrio,R.; Issaly,N.; Flanagan,J.; Roller,M.; Tomás-Barberán,F.A.; et al. A Rosemary Extract Rich in Carnosic Acid Selectively Modulates Caecum Microbiota and Inhibits β-Glucosidase Activity,Altering Fiber and Short Chain Fatty Acids Fecal Excretion in Lean and Obese Female Rats. PLoS ONE 2014,9,e94687. [CrossRef] [PubMed]